FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
1.329
-0.031 (-2.26%)
Sep 25, 2026, 9:12 AM EDT - Market open
FibroBiologics Employees
FibroBiologics had 15 employees as of December 31, 2025. The number of employees increased by 2 or 15.38% compared to the previous year.
Employees
15
Change (1Y)
2
Growth (1Y)
15.38%
Revenue / Employee
n/a
Profits / Employee
-$1,209,267
Market Cap
9.25M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 15 | 2 | 15.38% |
| Dec 31, 2024 | 13 | 3 | 30.00% |
| Dec 31, 2023 | 10 | 3 | 42.86% |
| Sep 30, 2023 | 8 | 1 | 14.29% |
| Jun 30, 2023 | 7 | - | - |
| Dec 31, 2022 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Senti Biosciences Holdings | 39 |
| Longeveron | 38 |
| Enlivex | 34 |
| Lunai Bioworks | 29 |
| Theriva Biologics | 16 |
| Soligenix | 14 |
| Azitra | 13 |
| Aprea Therapeutics | 8 |
FBLG News
- 2 days ago - FibroBiologics Transcript: Investor update - Transcripts
- 7 days ago - FibroBiologics Transcript: EGM 2026 - Transcripts
- 8 days ago - FibroBiologics Announces Closing of $0.5 Million Private Placement with Chief Scientific Officer - PRNewsWire
- 8 days ago - FibroBiologics Slides: Corporate presentation - Filings
- 16 days ago - FibroBiologics Proxy statement: Proxy filing - Filings
- 22 days ago - FibroBiologics announces USPTO issued patent on use of fibroblasts - TheFly
- 22 days ago - FibroBiologics Announces Issuance of New U.S. Patent for the Therapeutic Use of Fibroblasts in Wound Healing - PRNewsWire
- 24 days ago - FibroBiologics announces USPTO issued patent for Fibroblast Conditioned Media - TheFly